DraftKings Valuation
Is DKNG1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DKNG1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DKNG1 * (MX$716) is trading below our estimate of fair value (MX$1384.49)
Significantly Below Fair Value: DKNG1 * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DKNG1 *?
Other financial metrics that can be useful for relative valuation.
What is DKNG1 *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$18.86b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.7x |
Enterprise Value/EBITDA | -60.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does DKNG1 *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4.2x | ||
ALSEA * Alsea. de | 0.7x | 9.2% | Mex$49.7b |
1928 Sands China | 2.8x | 10.4% | HK$144.1b |
EVO Evolution | 10.4x | 14.4% | kr218.0b |
LVS Las Vegas Sands | 2.9x | 7.0% | US$32.2b |
DKNG1 * DraftKings | 4.6x | 15.2% | Mex$18.9b |
Price-To-Sales vs Peers: DKNG1 * is expensive based on its Price-To-Sales Ratio (4.6x) compared to the peer average (3.6x).
Price to Earnings Ratio vs Industry
How does DKNG1 *'s PE Ratio compare vs other companies in the South American Hospitality Industry?
Price-To-Sales vs Industry: DKNG1 * is expensive based on its Price-To-Sales Ratio (4.6x) compared to the South American Hospitality industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is DKNG1 *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 4.6x |
Fair PS Ratio | 1.8x |
Price-To-Sales vs Fair Ratio: DKNG1 * is expensive based on its Price-To-Sales Ratio (4.6x) compared to the estimated Fair Price-To-Sales Ratio (1.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$716.00 | Mex$962.27 +34.4% | 17.8% | Mex$1,643.59 | Mex$646.36 | n/a | 35 |
Jun ’25 | Mex$595.00 | Mex$887.42 +49.1% | 17.7% | Mex$1,509.95 | Mex$593.80 | n/a | 35 |
May ’25 | Mex$743.10 | Mex$876.25 +17.9% | 18.6% | Mex$1,548.82 | Mex$544.64 | n/a | 35 |
Apr ’25 | Mex$732.01 | Mex$843.27 +15.2% | 18.4% | Mex$1,474.20 | Mex$530.05 | n/a | 34 |
Mar ’25 | Mex$732.00 | Mex$831.58 +13.6% | 13.1% | Mex$1,022.88 | Mex$545.54 | n/a | 32 |
Feb ’25 | Mex$692.75 | Mex$703.99 +1.6% | 15.4% | Mex$860.44 | Mex$387.20 | n/a | 32 |
Jan ’25 | Mex$609.80 | Mex$679.32 +11.4% | 15.1% | Mex$849.43 | Mex$382.24 | n/a | 31 |
Dec ’24 | Mex$672.97 | Mex$679.30 +0.9% | 15.6% | Mex$859.53 | Mex$386.79 | n/a | 31 |
Nov ’24 | Mex$490.00 | Mex$646.14 +31.9% | 15.1% | Mex$794.35 | Mex$406.20 | n/a | 31 |
Oct ’24 | Mex$509.75 | Mex$634.61 +24.5% | 15.1% | Mex$778.07 | Mex$397.88 | n/a | 31 |
Sep ’24 | Mex$516.00 | Mex$598.51 +16.0% | 17.6% | Mex$749.91 | Mex$383.48 | n/a | 30 |
Aug ’24 | Mex$534.99 | Mex$509.59 -4.7% | 18.4% | Mex$653.03 | Mex$334.89 | n/a | 30 |
Jul ’24 | Mex$463.59 | Mex$481.34 +3.8% | 20.2% | Mex$667.37 | Mex$290.90 | n/a | 31 |
Jun ’24 | Mex$438.00 | Mex$488.96 +11.6% | 20.4% | Mex$697.94 | Mex$304.23 | Mex$595.00 | 31 |
May ’24 | Mex$396.00 | Mex$433.76 +9.5% | 20.6% | Mex$681.29 | Mex$268.93 | Mex$743.10 | 31 |
Apr ’24 | Mex$338.00 | Mex$442.58 +30.9% | 22.4% | Mex$705.16 | Mex$241.24 | Mex$732.01 | 30 |
Mar ’24 | Mex$331.80 | Mex$436.38 +31.5% | 22.3% | Mex$698.22 | Mex$238.86 | Mex$732.00 | 30 |
Feb ’24 | Mex$302.74 | Mex$384.77 +27.1% | 35.5% | Mex$900.92 | Mex$225.23 | Mex$692.75 | 29 |
Jan ’24 | Mex$216.95 | Mex$408.03 +88.1% | 35.1% | Mex$938.23 | Mex$234.56 | Mex$609.80 | 28 |
Dec ’23 | Mex$301.49 | Mex$408.03 +35.3% | 35.1% | Mex$938.23 | Mex$234.56 | Mex$672.97 | 28 |
Nov ’23 | Mex$325.00 | Mex$495.73 +52.5% | 36.4% | Mex$1,030.35 | Mex$237.77 | Mex$490.00 | 27 |
Oct ’23 | Mex$312.54 | Mex$532.06 +70.2% | 33.3% | Mex$1,047.20 | Mex$322.22 | Mex$509.75 | 25 |
Sep ’23 | Mex$312.95 | Mex$526.44 +68.2% | 32.9% | Mex$1,046.18 | Mex$321.90 | Mex$516.00 | 27 |
Aug ’23 | Mex$283.80 | Mex$524.34 +84.8% | 42.7% | Mex$1,231.94 | Mex$266.92 | Mex$534.99 | 27 |
Jul ’23 | Mex$238.98 | Mex$553.91 +131.8% | 41.1% | Mex$1,207.74 | Mex$261.68 | Mex$463.59 | 28 |
Jun ’23 | Mex$267.01 | Mex$554.35 +107.6% | 40.6% | Mex$1,182.21 | Mex$256.15 | Mex$438.00 | 26 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.